Verified publication
A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.
Verified PubMed record for Thymosin Alpha 1: A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.
PubMed metadata verifiedQuality: Not assessedLow confidence
Study metadata
- Journal
- The Journal of infectious diseases
- Publication year
- 2023
- Study type
- Human randomized trial
- Species
- Human
- Evidence grade
- Grade A
- Extraction depth
- PubMed metadata verified
- Study quality
- Not assessed
- Confidence
- Low confidence
- Sample size
- Not stated in indexed abstract
Structured extraction
- Population
- Human participants; population details require article-level extraction.
- Intervention
- Intervention details require abstract or full-text extraction before use.
- Comparator
- Not extracted from PubMed metadata.
- Duration
- Not extracted from PubMed metadata.
- Primary endpoint
- Primary endpoint not extracted into Atlas unless stated in the indexed abstract.
- Secondary endpoints
- No secondary endpoints extracted.
- Funding source
- Not extracted from PubMed metadata.
Findings and extraction notes
- PubMed indexes this publication under PMID 36056913; Atlas verified title, journal, year, and DOI metadata where available before publishing the page.
- The record is linked to Thymosin Alpha 1 for literature mapping, but Atlas has not promoted the indexed metadata into a mechanistic or clinical outcome claim.
Limitations
- Phase 3 metadata verification confirms citation identity; it does not replace full independent extraction of methods, endpoints, or effect sizes.
- Interpretation should remain limited to the publication type, species context, and verified PubMed metadata shown on this page.